A polysomnographic placebo-controlled evaluation of the efficacy and safety of eszopiclone relative to placebo and zolpidem in the treatment of primary insomnia.
Erman MK, et al.
Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia.
Krystal AD, et al.
A polysomnography study of eszopiclone in elderly patients with insomnia.
McCall WV, et al.
An assessment of the efficacy and safety of eszopiclone in the treatment of transient insomnia in healthy adults.
Rosenberg R, et al.
A 2-week efficacy and safety study of eszopiclone in elderly patients with primary insomnia.
Scharf M, et al.
Efficacy and safety of eszopiclone across 6-weeks of treatment for primary insomnia.
Zammit GK, et al.
back
are registered trademarks of Sumitomo Dainippon Pharma Co., Ltd.
